Wendy Wilson

Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark survey

Ruben A. Mesa, Carole B. Miller, Maureen Thyne et al. · BMC Cancer · 2016 · 191 citations · Full text

Medicine, Hematology, Internal Medicine +15

Allogeneic hematopoietic cell transplantation after conditioning with 131I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

John M. Pagel, Theodore A. Gooley, Joseph G. Rajendran et al. · Blood · 2009 · 185 citations · Full text

Medicine, Hematology, Immunology +17

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS

H. Joachim Deeg, Bart L. Scott, Min Fang et al. · Blood · 2012 · 154 citations · Full text

Medicine, Hematology, Oncology +16

Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary

Katherine A. Thornton, Geoffrey Kim, V. Ellen Maher et al. · Clinical Cancer Research · 2012 · 147 citations

Medicine, Oncology, Pharmacology +7

Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey

Ruben A. Mesa, Carole B. Miller, Maureen Thyne et al. · Cancer · 2016 · 91 citations · Full text

Medicine, Hematology, Oncology +17